Fundraising FoxUCAN
Woodbridge, US · 1 known investors
Find your way into UCAN
Sign up to see every warm intro you have to UCAN
- Paths you didn't know you had: your email and LinkedIn already hold routes to the UCAN team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
UCAN produces sports nutrition products powered by LIVSTEADY, a proprietary low-glycemic carbohydrate formulation designed to deliver sustained energy without rapid blood sugar spikes. The company offers energy gels, bars, drink mixes, and hydration products marketed to athletes and active consumers.
Founders & leadership
DF
David FeldmanExecutive
RR
Ramesh RatanExecutive
J
Jonah
Board
SS
Stephen Squinto, Sr.Board director
K(
Kannankote (Sri) SrikanthBoard director
Investors · 1
S2G Investmentslisted by S2G InvestmentsChicago · $1M – $5M
How we know: S2G Investments's portfolio page · press coverage · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$21.5M disclosed across 4 rounds · 2009–2022
▶$10.7MraisedJun 2023 · 21 investors · OtherRule 506(b)
▶$10.7MraisedJun 2023 · 21 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Clive SirkinDirector
- Jonathan KucinskiDirector
- Elena SukachevaExecutive Officer, Director
- Peter KaufmanExecutive Officer
- Arthur ChowDirector
- Shoba MuraliDirector
- Jack HerpokExecutive Officer
- Offering amount
- $10.7M
- Amount sold
- $10.7M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.7MraisedMay 2018 · 9 investors · BiotechnologyRule 506(b)
▶$5.7MraisedMay 2018 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Peter KaufmanExecutive Officer, Director
- David FeldmanExecutive Officer, Director
- Shoba MuraliExecutive Officer, Director
- Kannankote SrikanthDirector
- Stephen SquintoDirector
- Offering amount
- $5.7M
- Amount sold
- $5.7M
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.5MraisedMar 2018 · 14 investors · BiotechnologyRule 506(b)
▶$2.5MraisedMar 2018 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Stephen Squinto, Sr.Director
- Kannankote (Sri) SrikanthDirector
- Shoba MuraliExecutive Officer, Director, Promoter
- David FeldmanExecutive Officer, Director, Promoter
- Ramesh RatanExecutive Officer
- Peter KaufmanExecutive Officer, Director, Promoter
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- First sale
- Apr 2012
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.5MraisedMar 2018 · 46 investors · BiotechnologyRule 506(b)
▶$2.5MraisedMar 2018 · 46 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Peter KaufmanExecutive Officer, Director
- Ramesh RatanExecutive Officer
- David FeldmanExecutive Officer, Director
- Kannankote (Sri) SrikanthDirector
- Shoba MuraliExecutive Officer, Director
- Stephen Squinto, Sr.Director
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- First sale
- Dec 2009
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does UCAN do?
- UCAN produces sports nutrition products powered by LIVSTEADY, a proprietary low-glycemic carbohydrate formulation designed to deliver sustained energy without rapid blood sugar spikes. The company offers energy gels, bars, drink mixes, and hydration products marketed to athletes and active consumers.
- Who are UCAN's investors?
- UCAN's investors include S2G Investments.
- How much funding has UCAN raised?
- UCAN has disclosed $21.5M raised across 4 rounds.
- Where is UCAN headquartered?
- UCAN is headquartered in Woodbridge, US.